Chantal Tobin

Toronto, ON M5G2M9, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Unveiling the developmental and tumor-suppressive roles of the p53 variant p53psi.

Unveiling the developmental and tumor-suppressive roles of the p53 variant p53psi.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 23, 2026

Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer.

Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer.

Journal: International journal of molecular sciences

Published: February 08, 2026

Mutant IDH1 cooperates with NPM1c or FLT3ITD to drive distinct myeloid diseases and molecular outcomes.

Mutant IDH1 cooperates with NPM1c or FLT3ITD to drive distinct myeloid diseases and molecular outcomes.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 16, 2025

B cell-derived acetylcholine mitigates skin inflammation in mice through α9 nicotinic acetylcholine receptor-mediated signaling.

B cell-derived acetylcholine mitigates skin inflammation in mice through α9 nicotinic acetylcholine receptor-mediated signaling.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 23, 2025

Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial.

Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial.

Journal: Nature communications

Published: August 22, 2024

Identification of an Optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2.

Identification of an Optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: May 01, 2023

Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells.

Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 18, 2023

IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.

IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.

Journal: Cancer cell

Published: February 24, 2022

Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinoma.

Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinoma.

Journal: Nature cancer

Published: September 28, 2021

Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids.

Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids.

Journal: Nature communications

Published: August 31, 2020

Concerted roles of PTEN and ATM in controlling hematopoietic stem cell fitness and dormancy.

Concerted roles of PTEN and ATM in controlling hematopoietic stem cell fitness and dormancy.

Journal: The Journal of clinical investigation

Published: July 15, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026